Literature DB >> 15965192

Cholinesterase inhibitors for treatment of dementia associated with Parkinson's disease.

J L Cummings.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15965192      PMCID： PMC1739703          DOI： 10.1136/jnnp.2004.061499

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Cognitive changes in Parkinson's disease during subthalamic stimulation: a clinicopathologic study.

Authors:  F Valldeoriola; E Tolosa; M Alegret; E Tolosa; M J Rey; O Morsi; M Pilleri; J Rumià
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

2.  Partial correlation coefficient for a study with repeated measurements.

Authors:  Guogen Shan; Ece Bayram; Jessica Z K Caldwell; Justin B Miller; Jay J Shen; Shawn Gerstenberger
Journal:  Stat Biopharm Res       Date:  2020-07-20       Impact factor: 1.452

Review 3.  Rational pharmacological approaches for cognitive dysfunction and depression in Parkinson's disease.

Authors:  Maritza Sandoval-Rincón; Michel Sáenz-Farret; Adán Miguel-Puga; Federico Micheli; Oscar Arias-Carrión
Journal:  Front Neurol       Date:  2015-03-31       Impact factor: 4.003

4.  East Indian sandalwood (Santalum album L.) oil confers neuroprotection and geroprotection in Caenorhabditis elegans via activating SKN-1/Nrf2 signaling pathway.

Authors:  A Mohankumar; G Shanmugam; D Kalaiselvi; C Levenson; S Nivitha; G Thiruppathi; P Sundararaj
Journal:  RSC Adv       Date:  2018-10-02       Impact factor: 4.036
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.